Detecting ALK, ROS1, and RET fusions and the METΔex14 splicing variant in liquid biopsies of non‐small‐cell lung cancer patients using RNA‐based techniques

Autor: Ana Giménez‐Capitán, Estela Sánchez‐Herrero, Lucía Robado de Lope, Andrés Aguilar‐Hernández, Ivana Sullivan, Virginia Calvo, Irene Moya‐Horno, Santiago Viteri, Carlos Cabrera, Cristina Aguado, Noelia Armiger, Joselyn Valarezo, Clara Mayo‐de‐las‐Casas, Noemí Reguart, Rafael Rosell, Mariano Provencio, Atocha Romero, Miguel A. Molina‐Vila

Publikováno v: Molecular Oncology, Vol 17, Iss 9, Pp 1884-1897 (2023)

ALK, ROS1, and RET fusions and MET∆ex14 variant associate with response to targeted therapies in non‐small‐cell lung cancer (NSCLC). Technologies for fusion testing in tissue must be adapted to liquid biopsies, which are often the only material

Externí odkaz: https://doaj.org/article/895f32ea609d4f95922800c025292cd9

Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC)

Autor: Irene Moya-Horno, Santiago Viteri, Niki Karachaliou, Rafael Rosell

Publikováno v: Therapeutic Advances in Medical Oncology, Vol 10 (2018)

Treatment for advanced non-small cell lung cancer (NSCLC) has been significantly improved in recent years with the incorporation of drugs targeting antiangiogenesis and more specifically genomic alterations such as the EGFR mutations and ALK transloc

Externí odkaz: https://doaj.org/article/ad46e893b408475a85c0adbc89507ada

Author response for 'Detecting ALK , ROS1 and RET fusions and the METΔex14 splicing variant in liquid biopsies of non‐small cell lung cancer patients using RNA ‐based techniques'

Autor: null Ana Giménez‐Capitán, null Estela Sánchez‐Herrero, null Lucía Robado de Lope, null Andrés Aguilar‐Hernández, null Ivana Sullivan, null Virginia Calvo, null Irene Moya‐Horno, null Santiago Viteri, null Carlos Cabrera, null Cristina Aguado, null Noelia Armiger, null Joselyn Valarezo, null Clara Mayo‐de‐las‐Casas, null Noemí Reguart, null Rafael Rosell, null Mariano Provencio, null Atocha Romero, null Miguel A. Molina‐Vila

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::274602076175be641cf1b3d3ac9067f0
https://doi.org/10.1002/1878-0261.13468/v2/response1

Monocle tumor as tonsillar squamous cell carcinoma metastasis: resolution after chemotherapy treatment

Autor: María T. Fernández‐Figueras, Alejandro Lobato-Berezo, Irene Moya‐Horno, Ramon M. Pujol, Antonio Campoy

Publikováno v: International Journal of Dermatology. 57:498-500

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ac82fa1036cb7192105a93f41f690aab
https://doi.org/10.1111/ijd.13917

Prospective detection of mutations in cerebrospinal fluid, pleural effusion, and ascites of advanced cancer patients to guide treatment decisions

Autor: Giancarlo Troncone, Umberto Malapelle, Santiago Viteri-Ramirez, Clara Mayo-de-las-Casas, Noemí Reguart, Niki Karachaliou, Ariadna Balada-Bel, Maria José Catalán, Ana Blasco, Beatriz García-Peláez, Alejandro Martinez-Bueno, Núria Jordana-Ariza, Mónica Garzón-Ibáñez, Rafael Rosell, Raquel Campos, Sergio Villatoro, Miguel Angel Molina-Vila, Irene Moya-Horno, R. Blanco, Maria Gonzalez-Cao, Margarita Majem, Xavier Gonzalez

Publikováno v: Molecular Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Molecular Oncology, Vol 13, Iss 12, Pp 2633-2645 (2019)
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau

Many advanced cases of cancer show central nervous system, pleural, or peritoneal involvement. In this study, we prospectively analyzed if cerebrospinal fluid (CSF), pleural effusion (PE), and/or ascites (ASC) can be used to detect driver mutations a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74031d25b8b6b6755deee5fc272706e0
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2889